Scandinavian ChemoTech Financials
| CMOTEC-B | SEK 1.66 0.09 5.14% |
Scandinavian |
Understanding current and past Scandinavian ChemoTech Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Scandinavian ChemoTech's financial statements are interrelated, with each one affecting the others. For example, an increase in Scandinavian ChemoTech's assets may result in an increase in income on the income statement.
Please note, the presentation of Scandinavian ChemoTech's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Scandinavian ChemoTech's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Scandinavian ChemoTech's management manipulating its earnings.
Scandinavian ChemoTech Stock Summary
Scandinavian ChemoTech competes with Vicore Pharma, Enorama Pharma, Xintela AB, Alzinova, and Cantargia. Scandinavian ChemoTech AB provides cancer care and pain management solutions. Scandinavian ChemoTech AB is headquartered in Malmo, Sweden. Scandinavian ChemoTech is traded on Stockholm Stock Exchange in Sweden.| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0009242654 |
| Business Address | Medicon Village, Lund, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | chemotech.se |
| Phone | 46 1 0218 9300 |
| Currency | SEK - Swedish Kronor |
You should never invest in Scandinavian ChemoTech without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Scandinavian Stock, because this is throwing your money away. Analyzing the key information contained in Scandinavian ChemoTech's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Scandinavian ChemoTech Key Financial Ratios
Scandinavian ChemoTech's financial ratios allow both analysts and investors to convert raw data from Scandinavian ChemoTech's financial statements into concise, actionable information that can be used to evaluate the performance of Scandinavian ChemoTech over time and compare it to other companies across industries.| Return On Equity | -1.17 | |||
| Return On Asset | -0.51 | |||
| Beta | 1.56 |
Scandinavian Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Scandinavian ChemoTech's current stock value. Our valuation model uses many indicators to compare Scandinavian ChemoTech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Scandinavian ChemoTech competition to find correlations between indicators driving Scandinavian ChemoTech's intrinsic value. More Info.Scandinavian ChemoTech AB is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Scandinavian ChemoTech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Scandinavian ChemoTech's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Scandinavian ChemoTech Systematic Risk
Scandinavian ChemoTech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Scandinavian ChemoTech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Scandinavian ChemoTech correlated with the market. If Beta is less than 0 Scandinavian ChemoTech generally moves in the opposite direction as compared to the market. If Scandinavian ChemoTech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Scandinavian ChemoTech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Scandinavian ChemoTech is generally in the same direction as the market. If Beta > 1 Scandinavian ChemoTech moves generally in the same direction as, but more than the movement of the benchmark.
Scandinavian ChemoTech Thematic Clasifications
Scandinavian ChemoTech AB is part of IT investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Information technology and IT services. Information Technology (IT) companies and IT service providers across different domains
This theme covers Information technology and IT services. Information Technology (IT) companies and IT service providers across different domains. Get More Thematic Ideas
| IT | View |
Scandinavian ChemoTech January 6, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Scandinavian ChemoTech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Scandinavian ChemoTech AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Scandinavian ChemoTech AB based on widely used predictive technical indicators. In general, we focus on analyzing Scandinavian Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Scandinavian ChemoTech's daily price indicators and compare them against related drivers.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 25.44 | |||
| Value At Risk | (7.21) | |||
| Potential Upside | 7.19 |
Complementary Tools for Scandinavian Stock analysis
When running Scandinavian ChemoTech's price analysis, check to measure Scandinavian ChemoTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scandinavian ChemoTech is operating at the current time. Most of Scandinavian ChemoTech's value examination focuses on studying past and present price action to predict the probability of Scandinavian ChemoTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scandinavian ChemoTech's price. Additionally, you may evaluate how the addition of Scandinavian ChemoTech to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |